Vycor Medical, Inc.
VYCO
$0.175
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.25% | -7.37% | -53.66% | -107.84% | -18.97% |
| Total Depreciation and Amortization | 3.41% | 5.57% | 5.10% | 1.80% | 0.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 387.80% | 169.48% | 178.90% | 31.48% | -82.48% |
| Change in Net Operating Assets | -126.58% | 9.14% | 167.03% | 1,756.30% | 506.85% |
| Cash from Operations | -110.32% | 367.16% | 104.42% | 1,193.68% | 210.10% |
| Capital Expenditure | 17.02% | 55.32% | 55.32% | -221.88% | -2,450.00% |
| Sale of Property, Plant, and Equipment | -50.00% | -240.00% | -100.00% | -100.00% | -66.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 17.39% | 46.07% | 55.91% | -229.03% | -1,020.00% |
| Total Debt Issued | -0.65% | -3.33% | -3.33% | -64.10% | -59.20% |
| Total Debt Repaid | 0.00% | -8.49% | -9.06% | 44.53% | 7.68% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.43% | -447.06% | -3,900.00% | -110.39% | -104.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.74% | 538.46% | 137.93% | 141.80% | 565.66% |